Search Results - Majd M. Alhamdan
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness of Ribociclib in HER2- negative breast cancer: A synthesis of current evidence by Wedad H. Alotaibi, Majd M. Alhamdan, Bander Balkhi
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book